Urinary excretion of three nucleic acid oxidation adducts and isoprostane F2α measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers (Q40550795)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 15, 2003

Language	Label	Description	Also known as
English	Urinary excretion of three nucleic acid oxidation adducts and isoprostane F2α measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers	scientific article published on November 15, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Urinary excretion of three nucleic acid oxidation adducts and isoprostane F2α measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers (English)

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

author name string

Lynn Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Frank Gucciardo

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Wei Ping

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Alaa Ahmed

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

S. Mitchell Harman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607529

30 March 2024

Panayiotis D. Tsitouras

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607529

30 March 2024

Christopher B. Heward

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607529

30 March 2024

Peter D. Reaven

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607529

30 March 2024

Richard G. Cutler

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607529

30 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607529

30 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

15 November 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607529

30 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0891584903005161?httpAccept=text/xml

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

https://api.elsevier.com/content/article/PII:S0891584903005161?httpAccept=text/plain

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Free Radical Biology and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1301-1309

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

describes a project that uses

liquid chromatography–mass spectrometry

1 reference

based on heuristic

inferred from title

Oxidative stress, caloric restriction, and aging

1

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Review: Oxidative stress and disease

3

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse

4

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2-isoprostanes) are not correlated in healthy human subjects

7

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidative DNA damagein vivo: Relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion

10

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

11

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet

12

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry

13

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

14

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer

15

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients

18

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

19

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidative stress indices in IDDM subjects with and without long-term diabetic complications

20

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Effect of diet on cancer development: is oxidative DNA damage a biomarker?

21

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Vitamin E consumption and the risk of coronary disease in women

22

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

23

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group

24

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Cigarette smoking induces an increase in oxidative DNA damage, 8- hydroxydeoxyguanosine, in a central site of the human lung

26

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses.

28

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase

29

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

The peripheral vascular consequences of smoking

30

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

C-reactive protein and myocardial infarction

31

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Smoking influences the atherogenic potential of low-density lipoprotein

32

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Low Density Lipoprotein Oxidation and Its Pathobiological Significance

33

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Mortality in relation to smoking: 40 years' observations on male British doctors

34

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage

35

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer

37

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index

42

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion.

43

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

44

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers

45

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane)

46

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Modulation of oxidant stress in vivo in chronic cigarette smokers

47

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation

48

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study

49

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases

50

1 reference

10.1016/J.FREERADBIOMED.2003.07.003

https://api.crossref.org/works/10.1016/J.FREERADBIOMED.2003.07.003

30 March 2024

Identifiers

10.1016/J.FREERADBIOMED.2003.07.003

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40550795&oldid=2114371677"